These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38792317)

  • 41. Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure.
    Henrysson J; Thunström E; Chen X; Fu M; Basic C
    ESC Heart Fail; 2023 Feb; 10(1):66-79. PubMed ID: 36161782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
    Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
    JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
    Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication and Outcome in Older Heart Failure Patients: Results from a Prospective Cohort Study.
    Garay DP; Saner H; Herzberg J; Hellige G; Arenja N
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931378
    [No Abstract]   [Full Text] [Related]  

  • 45. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction.
    Nauta JF; Santema BT; van der Wal MHL; Koops A; Warink-Riemersma J; van Dijk K; Inkelaar F; Prückl S; Suwijn J; van Deursen VM; Meijers WC; Coster J; Westenbrink BD; de Boer RA; Hummel Y; van Melle J; van Veldhuisen DJ; van der Meer P; Voors AA
    Neth Heart J; 2021 Jul; 29(7-8):383-393. PubMed ID: 34125353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of discharge checklist in guideline-directed medical therapy for heart failure patients.
    Rismiati H; Lee KS; Kang J; Cho HJ; Lee HY
    Korean J Intern Med; 2023 Mar; 38(2):195-206. PubMed ID: 36800678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.
    Mefford MT; Koyama SY; De Jesus J; Wei R; Fischer H; Harrison TN; Woo P; Reynolds K
    J Am Heart Assoc; 2022 Apr; 11(7):e023766. PubMed ID: 35322672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of kidney function on guideline-directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction.
    Bánfi-Bacsárdi F; Pilecky D; Vámos M; Majoros Z; Török GM; Borsányi TD; Dékány M; Solymossi B; Andréka P; Duray GZ; Kiss RG; Nyolczas N; Muk B
    Clin Cardiol; 2024 Feb; 47(2):e24244. PubMed ID: 38402552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups.
    Witting C; Zheng J; Tisdale RL; Shannon E; Kohsaka S; Lewis EF; Heidenreich P; Sandhu A
    JACC Heart Fail; 2023 Feb; 11(2):161-172. PubMed ID: 36647925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
    Mebazaa A; Davison B; Chioncel O; Cohen-Solal A; Diaz R; Filippatos G; Metra M; Ponikowski P; Sliwa K; Voors AA; Edwards C; Novosadova M; Takagi K; Damasceno A; Saidu H; Gayat E; Pang PS; Celutkiene J; Cotter G
    Lancet; 2022 Dec; 400(10367):1938-1952. PubMed ID: 36356631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guideline Directed Medical Therapy at Discharge and Further Uptitration Leading to Reduction in Indication for Prophylactic ICD Implantation during Protected Waiting Period.
    Waezsada E; Hutter J; Kahle P; Yogarajah J; Sperzel J; Kuniss M; Neumann T; Esser H; Hamm C; Hain A
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry.
    Inciardi RM; Vaduganathan M; Lombardi CM; Gussago C; Agostoni P; Ameri P; Aspromonte N; Calò L; Cameli M; Carluccio E; Carugo S; Cipriani M; De Caterina R; De Ferrari GM; Emdin M; Fornaro A; Guazzi M; Iacoviello M; Imazio M; La Rovere MT; Leonardi S; Maccallini M; Masarone D; Moschini L; Palazzuoli A; Patti G; Pedretti RFE; Perrone Filardi P; Piepoli MF; Potena L; Salzano A; Sciacqua A; Senni M; Sinagra G; Specchia C; Taddei S; Vizza D; Savarese G; Rosano G; Volterrani M; Metra M;
    Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38923140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
    Beles M; Masuy I; Verstreken S; Bartunek J; Dierckx R; Heggermont W; Oeste C; De Boeck M; Fovel I; Maris M; Vermeulen Z; Vanderheyden M
    ESC Heart Fail; 2023 Aug; 10(4):2269-2280. PubMed ID: 37095712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction.
    Seferović PM; Polovina M; Adlbrecht C; Bělohlávek J; Chioncel O; Goncalvesová E; Milinković I; Grupper A; Halmosi R; Kamzola G; Koskinas KC; Lopatin Y; Parkhomenko A; Põder P; Ristić AD; Šakalytė G; Trbušić M; Tundybayeva M; Vrtovec B; Yotov YT; Miličić D; Ponikowski P; Metra M; Rosano G; Coats AJS
    Eur J Heart Fail; 2021 Dec; 23(12):1999-2007. PubMed ID: 34755422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Guideline-Directed Medical Therapy for Outpatients Living with Heart Failure with Reduced Ejection Fraction.
    McVannel T; Albers L; Kosar L; Reid B; Yeung C; Siddiqui M; Baran O
    Can J Hosp Pharm; 2024; 77(1):e3373. PubMed ID: 38482388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients.
    Clark KM; Mahboob F; Evans J; Sun JH; Wang N
    Heart Lung Circ; 2024 Mar; 33(3):281-291. PubMed ID: 38365495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.
    Shahid I; Khan MS; Fonarow GC; Butler J; Greene SJ
    Prog Cardiovasc Dis; 2024; 82():61-69. PubMed ID: 38244825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of acute decompensated heart failure in patients with heart failure with mildly reduced ejection fraction.
    Schmitt A; Schupp T; Reinhardt M; Abel N; Lau F; Forner J; Ayoub M; Mashayekhi K; Weiß C; Akin I; Behnes M
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(2):225-241. PubMed ID: 37950915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.